Correlation Between Elevai Labs, and AtriCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevai Labs, and AtriCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevai Labs, and AtriCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevai Labs, Common and AtriCure, you can compare the effects of market volatilities on Elevai Labs, and AtriCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevai Labs, with a short position of AtriCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevai Labs, and AtriCure.

Diversification Opportunities for Elevai Labs, and AtriCure

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Elevai and AtriCure is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Elevai Labs, Common and AtriCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AtriCure and Elevai Labs, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevai Labs, Common are associated (or correlated) with AtriCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AtriCure has no effect on the direction of Elevai Labs, i.e., Elevai Labs, and AtriCure go up and down completely randomly.

Pair Corralation between Elevai Labs, and AtriCure

Given the investment horizon of 90 days Elevai Labs, Common is expected to under-perform the AtriCure. In addition to that, Elevai Labs, is 3.2 times more volatile than AtriCure. It trades about -0.16 of its total potential returns per unit of risk. AtriCure is currently generating about 0.0 per unit of volatility. If you would invest  4,409  in AtriCure on August 27, 2024 and sell it today you would lose (835.00) from holding AtriCure or give up 18.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy56.04%
ValuesDaily Returns

Elevai Labs, Common  vs.  AtriCure

 Performance 
       Timeline  
Elevai Labs, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevai Labs, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
AtriCure 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AtriCure are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, AtriCure exhibited solid returns over the last few months and may actually be approaching a breakup point.

Elevai Labs, and AtriCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevai Labs, and AtriCure

The main advantage of trading using opposite Elevai Labs, and AtriCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevai Labs, position performs unexpectedly, AtriCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will offset losses from the drop in AtriCure's long position.
The idea behind Elevai Labs, Common and AtriCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world